As the proud mum of a fearless daughter studying in Europe, I decided to let her choose which logo to use for our new startup. She settled on a Kylin (Chinese version of a unicorn). She also wished me and all our partners around the globle the very best.

Our mission is to enable China healthcare companies to go global, while acting as the gateway for the best world health products to come into China!

Linda Zhang, Partner

As a senior finance executive, I have served many clients in multiple industries. But only when I took leadership roles with GE and Roche over 20 years ago, I started to truly appreciate the social attributes and responsibilities of the healthcare and pharmaceutical industry beyond its business purposes.

Innokylin provides a great platform with which I could work with a group of like minded partners with over 100 years’ combined experiences to help more innovative pharmaceutical and healthcare companies to grow and expand worldwide. And as a result, to enhance the quality of the life of the patients and help them to achieve a better life with their families!

Henry Yao, Partner

About 30 years ago, I started my career in New Jersey, where there are ~1,600 pharmaceutical, biotech, and medical device companies. I have witnessed their impact on patients, people, and communities. I am proud to have served big pharma like Roche and BMS, and biotech like Celgene and Hasten Pharma during their growth period.

I believe that a well-planned and executed global investment-R&D-biotech-commercialization ecosystem is the best way to serve patients and stakeholders and drive the development of innovative medicines worldwide. I am confident that Innokylin will make our unique contribution to this ecosystem.

Qing Meyerson, Partner

I began my career as a clinician, striving to “cure sometimes, relieve often, and comfort always.” During my 20+ years of experience with major pharmaceutical companies, I worked with teams to deliver innovative treatments in pursuit of that goal— “to cure”.

Now, with the Innokylin team, we aim to take this further by supporting biotech innovations. By connecting high-potential assets with the right partners, we help to accelerate the development and commercialization of innovative drugs, ultimately benefiting more patients and fostering the rise of biotech unicorns. This reflects Innokylin's vision and has inspired me in my daily work.

Joyce Zhang, Partner